Parameswaran Venugopal to Proto-Oncogene Proteins c-bcl-2
This is a "connection" page, showing publications Parameswaran Venugopal has written about Proto-Oncogene Proteins c-bcl-2.
Connection Strength
0.173
-
Phase 1 study of lenalidomide plus dose-adjusted EPOCH-R in patients with aggressive B-cell lymphomas with deregulated MYC and BCL2. Cancer. 2019 06 01; 125(11):1830-1836.
Score: 0.173
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.